Sarah Henry, PhD
Group Medical Director
Expertise:
Commercialization, Complex Therapies, Marketing and Advertising, Oncology, Product Launch, Stakeholder Engagement & Promotion (Patients, Payers, Providers)
Sarah has a Ph.D. in molecular and cellular biology and was a postdoctoral fellow at the University of Chicago. She has been working in pharmaceutical marketing for nine years.
As a Group Medical Director, Sarah has enjoyed translating scientific insights into promotional strategy across HCP and patient audiences. She has led scientific strategy for U.S. and global drug launches, providing medical insights to shape brand strategy and messaging development.
Throughout her career, Sarah has worked primarily in the oncology space across several disease states, including solid tumor and heme malignancies.